Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 93 Show results per page	View Search Criteria \| Help With Results


1.		Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				CRAD001C2241 NCT00419159

Last Modified: 5/27/2008 First Published: 3/17/2006


2.		Phase III Randomized Study of Celecoxib for Prevention of Capecitabine-Induced Palmar/Plantar Syndrome in Patients With Metastatic Breast or Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				MDA-CCC-0326 MDA-2005-0328, NCT00305643


3.		Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in theTreatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				EFC10262 AVE0005, EudraCT 2007-000820-42, NCT00561470


4.		Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				3c-03-19 NCT00159484

Last Modified: 5/24/2008 First Published: 2/17/2006


5.		Phase I/II Study of Dose-Dense and Dose-Intense Capecitabine in Combination With Alternating Full-Dose Irinotecan Hydrochloride and Oxaliplatin With or Without Bevacizumab in Patients With Metastatic or Locally Advanced Unresectable Colorectal Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				CASE-1205 NCI-7325, 7325, NCT00296062


6.		Vorinostat and IV 5FU/LV in Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				3C-05-3 NCT00336141

Last Modified: 10/1/2008 First Published: 10/24/2006


7.		Phase I/II Study of Erlotinib Hydrochloride and Cetuximab in Patients With Advanced Gastrointestinal, Head and Neck, Non-Small Cell Lung, or Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				VU-VICC-GI-0622 VICC-GI-0622, 6980, NCI-6980, NCT00397384


8.		Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				22706 NCT00390182


9.		Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				A4061020 NCT00460603


10.		Evaluation of Single Session Stereotactic Body Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				2005-0445 NCT00492817

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute